Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004910015 | SCV005574829 | uncertain significance | not specified | 2024-09-15 | criteria provided, single submitter | clinical testing | The p.G215V variant (also known as c.644G>T), located in coding exon 1 of the EGLN1 gene, results from a G to T substitution at nucleotide position 644. The glycine at codon 215 is replaced by valine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. |